Literature DB >> 7766534

Five factor model of schizophrenia: replication across samples.

J P Lindenmayer1, S Grochowski, R B Hyman.   

Abstract

In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drug-free period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766534     DOI: 10.1016/0920-9964(94)00041-6

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  70 in total

Review 1.  Symptom dimensions in the course of childhood-onset schizophrenia.

Authors:  D Bunk; C Eggers; M Klapal
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

2.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 3.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 4.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

5.  Classifying psychosis: when is the time ripe for changes?

Authors:  Oye Gureje
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

6.  Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm.

Authors:  William Perry; Arpi Minassian; Brook Henry; Meegin Kincaid; Jared W Young; Mark A Geyer
Journal:  Psychiatry Res       Date:  2010-05-14       Impact factor: 3.222

7.  Routine evaluation in first episode psychosis services: feasibility and results from the MiData project.

Authors:  Helen Fisher; Kate Theodore; Paddy Power; Brock Chisholm; Jo Fuller; Karl Marlowe; Katherine J Aitchison; Raj Tanna; John Joyce; Maxine Sacks; Thomas Craig; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-06-13       Impact factor: 4.328

8.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

9.  Cognitive binding in schizophrenia: weakened integration of temporal intersensory information.

Authors:  Wolfgang Tschacher; Claudia Bergomi
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

10.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.